Literature DB >> 14210849

THE PHYSIOLOGICAL DISPOSITION OF C14-NOREPINEPHRINE IN PATIENTS WITH ATOPIC DERMATITIS AND OTHER DERMATOSES.

L M SOLOMON, H E WENTZEL, E TULSKY.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; BLOOD CHEMICAL ANALYSIS; CARBON ISOTOPES; CLINICAL RESEARCH; DERMATITIS EXFOLIATIVA; DERMATITIS, ATOPIC; DERMATITIS, CONTACT; MYCOSIS FUNGOIDES; NOREPINEPHRINE; PHARMACOLOGY; PHYSIOLOGY; PSORIASIS; RADIOISOTOPE SCANNING; SCLERODERMA; SEBORRHEA; SKIN; SYPHILIS, CUTANEOUS; URINE

Mesh：

Substances：

Year:  1964        PMID： 14210849     DOI： 10.1038/jid.1964.142

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  7 in total

1.  [Acetylcholinesterase content of normal and neurodermatitic skin].

Authors:  J P Scheidegger
Journal:  Arch Klin Exp Dermatol       Date:  1966

2.  Investigations of thurfyl nicotinate and methacholine reactions in atopic dermatitis by photoelectric reflectometry and plethysmography.

Authors:  P Thyne; G Rajka
Journal:  Arch Dermatol Forsch       Date:  1974

3.  [Effects of central stimuli on pilocarpin- and adrenalin-induced sweating].

Authors:  J Rovenský; J Záhejský; V Radochová
Journal:  Arch Dermatol Forsch       Date:  1972

4.  Eruptive molluscum contagiosum in atopic dermatitis.

Authors:  L M Solomon; P Telner
Journal:  Can Med Assoc J       Date:  1966-11-05       Impact factor: 8.262

Review 5.  Pharmacophysiology of atopic dermatitis.

Authors:  J M Hanifin
Journal:  Clin Rev Allergy       Date:  1986-02

6.  Radioautography of noradrenaline-14-C in atopic dermatitis.

Authors:  L M Solomon; N J Nadler
Journal:  Can Med Assoc J       Date:  1967-04-22       Impact factor: 8.262

7.  Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects.

Authors:  C F Wahlgren; M Tengvall Linder; O Hägermark; A Scheynius
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.